| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 48 | 62 | 71 | 93 | 112 | 138 | 180 | 222 | 311 | 283 | 287 | 291 | 295 |
| Expenses | 46 | 61 | 67 | 87 | 108 | 131 | 170 | 198 | 287 | 279 | 276 | 292 | 295 |
| EBITDA | 2 | 1 | 4 | 6 | 4 | 7 | 9 | 25 | 24 | 4 | 11 | -1 | -0 |
| Operating Profit % | 2 % | 2 % | 5 % | 6 % | 3 % | 5 % | 5 % | 11 % | 8 % | 1 % | 4 % | -1 % | -1 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | 0 | 3 | 5 | 2 | 6 | 7 | 24 | 23 | 3 | 10 | -3 | -2 |
| Tax | 0 | 0 | 1 | 2 | 1 | 2 | 2 | 6 | 6 | 0 | 3 | 0 | 0 |
| Net Profit | 0 | 0 | 2 | 3 | 2 | 4 | 5 | 17 | 17 | 2 | 7 | -3 | -2 |
| EPS in ₹ | 1.02 | 0.97 | 5.68 | 10.41 | 4.97 | 13.71 | 17.26 | 55.62 | 53.83 | 7.00 | 23.02 | -10.72 | -7.10 |
Samrat Pharmachem
Samrat Pharmachem
227.95
-3.55
(-1.53%)
Market Cap
70.40 Cr
PE Ratio
-32.42
Volume
1,679.00
Day High - Low
231.50 - 220.00
52W High-Low
333.00 - 190.00
Key Fundamentals
Market Cap
70.40 Cr
EPS
-10.72
PE Ratio
-32.42
PB Ratio
1.05
Book Value
220.67
EBITDA
-1.30
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-4.86
Debt to Equity
0.15
Actual
Company News
View All News
Samrat Pharmachem AGM on Sep 23, 2026
Aug 27, 2026
Aug 27, 2026Samrat Pharmachem schedules 34th AGM for September 23, 2026. E-voting runs Sep 20-22. Share transfer books closed during this period.
Samrat Pharmachem Ltd reported a net profit of ₹87.60 lakh for Q1FY27, reversing the loss from the previous quarter. Revenue rose 5.4% YoY to ₹797.61 lakh.
Samrat Pharmachem Ltd appointed Divyesh J Shah & Associates as statutory auditors for five years, subject to shareholder approval.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,840.00 | #1 4,41,477.63 | 36.91 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 34.00 | |
9,322.00 | 2,47,469.81 | 85.36 | 11,067.00 | 13.95 | 2,568 | 65.50 | 63.65 | |
4,965.50 | 1,88,871.66 | 86.95 | 13,886.20 | 20.34 | 2,138 | 3.28 | 52.16 | |
1,119.10 | 1,12,607.65 | 24.28 | 27,657.90 | 17.64 | 5,026 | -34.90 | 45.64 | |
1,366.00 | 1,10,351.67 | 33.22 | 29,044.60 | 2.24 | 3,870 | -39.18 | 35.27 | |
1,969.00 | 1,06,297.76 | 95.94 | 6,867.80 | 22.01 | 890 | #1 123.93 | 68.28 | |
1,165.50 | 97,280.68 | 29.91 | 35,058.60 | 3.90 | 4,158 | -69.10 | 47.72 | |
1,679.80 | 96,651.98 | 25.88 | 34,145.20 | 5.56 | 3,503 | 25.21 | 57.04 | |
2,095.00 | 95,790.22 | #1 17.09 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 28.17 | |
2,280.00 | 94,163.08 | 44.87 | 14,636.40 | 14.85 | 1,938 | 29.13 | 37.57 |
Growth Rate
Revenue Growth
1.32 %
Net Income Growth
-146.48 %
Cash Flow Change
188.01 %
ROE
-149.04 %
ROCE
-120.08 %
EBITDA Margin (Avg.)
-111.51 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 26 | 36 | 36 | 41 | 40 | 58 | 57 | 85 | 117 | 122 | 122 | 124 |
| Fixed Assets | 7 | 7 | 7 | 7 | 7 | 7 | 9 | 10 | 11 | 11 | 11 | 12 |
| Current Assets | 19 | 28 | 28 | 33 | 33 | 50 | 47 | 71 | 99 | 103 | 103 | 104 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 4 | 4 |
| Other Assets | 19 | 27 | 29 | 34 | 33 | 50 | 48 | 75 | 104 | 108 | 107 | 108 |
| Total Equity & Liabilities | 26 | 36 | 36 | 41 | 40 | 58 | 57 | 85 | 117 | 122 | 122 | 124 |
| Current Liabilities | 12 | 21 | 19 | 21 | 19 | 34 | 27 | 37 | 53 | 56 | 50 | 56 |
| Non Current Liabilities | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Total Equity | 14 | 14 | 15 | 19 | 20 | 24 | 30 | 47 | 63 | 65 | 72 | 68 |
| Reserve & Surplus | 10 | 11 | 12 | 15 | 17 | 21 | 27 | 44 | 60 | 62 | 69 | 65 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -0 | -0 | -1 | -1 | 1 | -1 | 0 | 15 | -3 | -2 | -10 | 6 |
| Investing Activities | 0 | -2 | 1 | -2 | 2 | -2 | -3 | -1 | -3 | -0 | 0 | -3 |
| Operating Activities | -1 | -0 | -3 | 0 | 2 | -1 | 5 | 18 | -9 | 9 | -10 | 9 |
| Financing Activities | 0 | 2 | 1 | 2 | -4 | 2 | -2 | -2 | 10 | -11 | 1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 49.30 % | 49.30 % | 49.30 % | 49.65 % | 49.65 % | 49.65 % | 49.54 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.64 % | 48.95 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.24 % | 3.24 % | 3.24 % | 3.24 % | 3.24 % | 0.00 % | 3.24 % | 3.24 % | 3.24 % | 3.24 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.22 % | 0.22 % | 0.22 % | 0.00 % | 0.00 % | 3.24 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 42.44 % | 42.93 % | 42.96 % | 41.06 % | 37.41 % | 36.70 % | 37.09 % | 37.89 % | 38.48 % | 38.81 % | 42.58 % | 42.61 % | 41.69 % | 40.79 % | 41.34 % | 41.95 % | 41.58 % | 41.64 % | 41.73 % | 41.50 % | 41.75 % | 41.51 % |
| Others | 8.26 % | 7.77 % | 7.74 % | 9.29 % | 12.95 % | 13.65 % | 13.37 % | 13.47 % | 12.88 % | 12.55 % | 8.78 % | 8.75 % | 6.22 % | 7.11 % | 6.25 % | 5.72 % | 6.09 % | 6.04 % | 5.95 % | 6.17 % | 5.93 % | 6.16 % |
| No of Share Holders | 2,885 | 5,189 | 5,214 | 4,846 | 4,675 | 4,768 | 7,390 | 8,040 | 8,039 | 7,938 | 8,445 | 8,065 | 7,478 | 7,169 | 6,984 | 6,844 | 6,785 | 6,752 | 6,699 | 6,488 | 6,311 | 6,330 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.3 | 0.32 | 0.51 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2026 |  Annual General Meeting | NA | 23 Sept 2026 | 248.90 | 227.15 |
| 23 Sept 2022 |  Dividend | ₹ 1.00 /share | 22 Sept 2022 | 422.90 | 1,108.00 |
| 18 Sept 2023 | Dividend | ₹ 1.00 /share | 18 Sept 2023 | 491.50 | 399.85 |
| 19 Sept 2024 | Dividend | ₹ 1.00 /share | 19 Sept 2024 | 358.05 | 630.90 |
| 26 Sept 2024 | Annual General Meeting | NA | 26 Sept 2024 | 358.05 | 530.25 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 556.75 | 465.95 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 387.00 | 350.30 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 320.95 | 400.85 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 341.30 | 343.60 |
| 18 Sept 2025 | Dividend | ₹ 1.00 /share | 18 Sept 2025 | 400.85 | 326.65 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 400.85 | 317.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 316.50 | 272.00 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 230.50 | 234.10 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 200.00 | 248.90 |
| 14 Aug 2026 | Quarterly Result Announcement | NA | 14 Aug 2026 | 223.30 | 240.35 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2026
Sep 02, 2026Book Closure: Sunday September 20 2026 To Tuesday September 22 2026 (Both Days Inclusive)Aug 27, 2026
Aug 27, 202634Th Annual General Meeting Of Samrat Pharmachem Limited To Be Held On Wednesday September 23 2026Aug 27, 2026
Aug 27, 2026Reg. 34 (1) Annual Report.Aug 27, 2026
Aug 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2026
Aug 19, 2026Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held TodayAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJul 17, 2026
Jul 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2026
Jul 17, 2026Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended June 30 2026Jun 30, 2026
Jun 30, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 04, 2026
Jun 04, 2026Board Meeting Outcome for Outcome Of The Board MeetingMay 30, 2026
May 30, 2026Audited Financial Results For The Quarter And Year Ended 31 March 2026May 30, 2026
May 30, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
May 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 07, 2026
Apr 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Announcement under Regulation 30 (LODR)-Credit RatingMar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31 2026Mar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Feb 18, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held TodayFeb 13, 2026
Feb 13, 2026Un-Audited Financial Results For The Quarter Ended December 31 2025Feb 13, 2026
Feb 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2025Dec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Announcement under Regulation 30 (LODR)-Credit RatingDec 02, 2025
Dec 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2025
Nov 20, 2025Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Nov 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held TodayNov 14, 2025
Nov 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Corporate Action-Board approves DividendSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30 2025Sep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Book Closure: Friday September 19 2025 To Thursday September 25 2025 (Both Days Inclusive)Sep 04, 2025
Sep 04, 2025Record Date - Thursday September 18 2025Sep 04, 2025
Sep 04, 2025Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday September 25 2025Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Aug 19, 2025Un-Audited Financial Results For The Quarter Ended June 30 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Jul 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 01, 2025
Jul 01, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 26, 2025
Jun 26, 2025Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30-06-2025Jun 23, 2025
Jun 23, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Technical Indicators
RSI(14)
Neutral 41.73
ATR(14)
Volatile 11.34
STOCH(9,6)
Neutral 33.64
STOCH RSI(14)
Neutral 21.82
MACD(12,26)
Bearish -0.90
ADX(14)
Weak Trend 13.57
UO(9)
Bearish 56.90
ROC(12)
Downtrend And Accelerating -6.58
WillR(14)
Neutral -78.53
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
